How do you define the clinically relevant time horizon of alcohol exposure (e.g., past 1–3 months vs 6–12 months) to classify and manage patients whose intake fluctuates between MASLD-range and ALD- range drinking, particularly when prognostication or transplant evaluation is being considered?